Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
KP.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
MF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.1.192EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ME.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.49.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.441EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.509EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.293EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.225EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.637EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
AY.39 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.26 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.103 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-18609.9South Korea
LF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.29.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used